<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16201">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02895971</url>
  </required_header>
  <id_info>
    <org_study_id>EPIGETBO III (RB 12.157)</org_study_id>
    <nct_id>NCT02895971</nct_id>
  </id_info>
  <brief_title>Incidence of Venous Thromboembolism and Professional Practices in Brest Area</brief_title>
  <acronym>EPIGETBO III</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study estimate VTE incidence. Investigators prospectively record all cases
      of symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower limbs
      diagnosed between March 1, 2013 and February 28, 2014 in hospitals and in the community.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gathering information about potential factors predisposing Thromboembolic disease and treatments undertaken.</measure>
    <time_frame>two years after VTE</time_frame>
    <description>After two years, all medication given to the patient to treat his initial VTE will be recorded, as well as the ongoing of thromboembolic disease</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1416</enrollment>
  <condition>Venous Thromboembolism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with venous thromboembolism
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) diagnosis
             confirmed

          -  Patient living in Brest area from time of diagnosis

        Exclusion Criteria:

          -  invalid diagnosis

          -  asymptomatic event

          -  Main residence patient out of Brest area.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dominique Mottier</last_name>
    <email>dominique.mottier@chu-brest.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dominique Mottier</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domiqiue Mottier</last_name>
      <email>dominique.mottier@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>September 6, 2016</lastchanged_date>
  <firstreceived_date>August 29, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous Thromboembolism</keyword>
  <keyword>professional Practices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
